<![CDATA[Comparison of the 3 Most Commonly Used Modified PD-1 Inhibitors Plus Chemotherapy in Inoperable Wild-Type Non–...
Introduction Lung cancer remains the leading cause of cancer-related mortality globally, with non–small cell lung cancer (NSCLC) accounting for approximately 85% of cases.1 In China, the majority of patients with NSCLC are diagnosed at middle to advanced …